Global /South Korea /Healthcare /Drug Manufacturers - General /033270

Korea United Pharm Inc.

033270

• KRX: 033270 • Delayed

20,350KRW -1%

13.28 USD

As of 24 June 2026, Korea United Pharm Inc. has a market cap of $191.43M USD, ranking #21351 globally and #821 in South Korea. It ranks #1902 in the Healthcare sector, and #690 in the Drug Manufacturers - General industry.

Global Rank

21351

Country Rank

821

Sector Rank

1902

Industry Rank

690

Key Stats

Market Cap

$191.43MUSD

293.66B KRW

Revenue (TTM)

$105.24MUSD

161.44B KRW

EBITDA (TTM)

$19.89MUSD

30.47B KRW

Net Income (TTM)

$13.05MUSD

20.02B KRW

EBITDA Margin

19%

Profit Margin

12%

PE Ratio

16.3

Forward PE

7.1

PS Ratio

1.8

PB Ratio

1.7

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Duk-Young Kang open_in_new

Employees

665

Founded

1987

Website

kup.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1%	0.2%	-0.7%	8.7%	6.6%	7.8%	4.6%	-4.4%	-62%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	033270 한국유나이티드제약(주) ISIN: KR7033270000 Shares Out.: Shares Outstanding: 15.861M¹ Shares Float: 7.855M² TV: TradingView: KRX: 033270 SA: Stock Analysis: KRX: 033270 YF: Yahoo Finance: 033270.KS GF: Google Finance: KRX: 033270 BA: Barron's: 033270 MS: Morningstar: XKRX: 033270	20,350 KRW	TV: TradingView: KRX: 033270 SA: Stock Analysis: KRX: 033270 YF: Yahoo Finance: 033270.KS GF: Google Finance: KRX: 033270 BA: Barron's: 033270 MS: Morningstar: XKRX: 033270

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Korea United Pharm Inc.

Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.07B 13.91T KRW 5K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.72B 10.3T KRW 3K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.2B 7.97T KRW 3K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.92B 7.55T KRW 2K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.51B 6.92T KRW 2K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.41B 6.76T KRW 2K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 398K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 286K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 188K%	97.4	United States
Roche Holding AG SIX: RO	$316.71B 256.25B CHF 165K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$285.49B 215.59B GBP 149K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 143K%	15.1	United States

chevron_leftBack